Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use
Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy
BMI May Be Prognostic Tool For Types Of Breast Cancer
Postoperative Chemo Doesn’t Improve Survival, Study Finds
Risks Of Long-Term HRT Outweigh Benefits, WHI Finds
Cause Of Allergic Reaction To Cetuximab Found
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - In The Headlines: Increasing incidence of early-onset cancer is “a paradigm shift oncology isn’t quite prepared for”
- George Sigounas named the first-ever chief science advisor at NCI
- The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it” - Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State